The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 19, 2026
Snapshot (as of Oct 19, 2026): Takeda Pharmaceutical Company Limited (TAK) pays a $200.00 annual dividend, yielding 3.13% at $19.67/share. Next ex-dividend date 2026-03-31. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 3.13%
Annual Dividend: $200.00 per share
Payout Ratio: 279.9% (based on depressed trailing earnings — see safety analysis below)
Ex-Dividend Date: 2026-03-31
Dividend Frequency: semi-annually
Sector: Healthcare
Years of Dividend History: 19
Takeda Pharmaceutical Company Limited dividend investors are looking at a global pharmaceutical business built around gastroenterology, rare diseases, oncology, and plasma-derived therapies, with brands like Entyvio, Vyvanse, and Takhzyro anchoring its commercial portfolio. TAK currently yields 3.29%, paid semi-annually, with a trailing annual dividend rate of $200.00 per share based on actual TTM payments. The next ex-dividend date is March 31, 2026, with the last payment of $0.3390 per share. A beta of 0.10 means TAK stock moves very little with the broader market, which appeals to income-focused investors who prioritize low volatility over growth.
Takeda Pharmaceutical Company Limited pays out 279.9% of earnings as dividends, a payout ratio classified as high (above 75%). That figure sits well above 100%, meaning the current dividend is not covered by reported earnings, and Takeda Pharmaceutical Company Limited dividend safety depends on factors beyond net income, such as cash generation from its broad portfolio of specialty pharmaceuticals across gastroenterology, rare diseases, and oncology. The most significant data-supported pressure point is the dividend's own history: per-share payments have declined from $1.11 in 2012 to $0.60 in 2025, and the payout ratio at this level leaves little room to absorb further earnings weakness.
Takeda Pharmaceutical Company Limited dividend history shows a CAGR of -3.2% per year from 2009 to 2025. Per-share payments fell from $1.00 at the start of the window to $0.60 by 2025 (2026 data is a partial year and excluded from this calculation). The largest annual increase in the window was 13.5% in 2011, but the overall direction has been downward, with at least one year-over-year decline exceeding 5% recorded in the data.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | -3.2% | $0.66 (2022) | $0.60 (2025) |
| 5-Year | -6.8% | $0.85 (2020) | $0.60 (2025) |
| 10-Year | -2.0% | $0.73 (2015) | $0.60 (2025) |
TAK fits income-focused investors who accept a shrinking per-share dividend in exchange for low market sensitivity, given the stock's beta of 0.10. The current yield of 3.29% falls in the moderate (2-4%) range, but it sits below the 5-year average yield of 4.41%, which means buyers today are getting less income than the historical norm. The payout ratio of 279.9% is the defining trade-off: the dividend is not covered by earnings, and the per-share payment has declined at -3.2% annually since 2009. What an investor gets here is low volatility and a moderate yield. What they give up is dividend growth and payout coverage.
| Payment Date | Amount per Share |
|---|---|
| 2026-03-31 | $0.3083 |
| 2025-09-30 | $0.3221 |
| 2025-03-31 | $0.2760 |
| 2024-09-30 | $0.3261 |
| 2024-03-27 | $0.2922 |
| 2023-09-28 | $0.3191 |
| 2023-03-30 | $0.3100 |
| 2022-09-29 | $0.3296 |
| 2022-03-30 | $0.3301 |
| 2021-09-29 | $0.3969 |
| Year | Total Dividends |
|---|---|
| 2026 | $0.3083 |
| 2025 | $0.5981 |
| 2024 | $0.6183 |
| 2023 | $0.6291 |
| 2022 | $0.6597 |
Project income from TAK with the TAK dividend calculator or track your full portfolio with the dividend tracker.